Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
Director departure
|
|
Orgenesis Inc. (ORGS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 10/03/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 07/12/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/07/2023 |
8-K
| Quarterly results |
| 05/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 03/31/2023 |
8-K
| Quarterly results |
| 02/24/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"COMMON STOCK PURCHASE WARRANT orgenesis inc. Warrant Shares: _______ Initial Exercise Date: February 27, 2023 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 27, 2023 and on or prior to 5:00 p.m. on February 28, 2028 but not thereafter, to subscribe for and purchase from Orgenesis Inc., a Nevada corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that ...",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of February 23, 2023, between Orgenesis Inc., a Nevada corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act , the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree a...",
"PLACEMENT AGENCY AGREEMENT February 23, 2023 Vered Caplan Chief Executive Officer Orgenesis Inc. 20271 Goldenrod Lane Germantown, MD 20876",
"Orgenesis Inc. Announces Pricing of $3.7 Million Registered Direct Offering GERMANTOWN, Md., February 23, 2023 — Orgenesis, Inc. , a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 1,947,368 common stock and warrants to purchase up to 973,684 shares of common stock at a purchase price of $1.90 per share of common stock and accompanying warrants in a registered direct offering. The aggregate gross proceeds to the Company are expected to be approximately $3.7 million before deducting the placement agent’ s fees and other offering expenses payable by the Company. The warrants have an exercise price of $1.90 per share, are ex..." |
|
| 01/18/2023 |
8-K
| Quarterly results |
| 01/13/2023 |
8-K
| Quarterly results |
| 12/19/2022 |
8-K
| Quarterly results |
| 12/19/2022 |
8-K
| Quarterly results |
| 11/07/2022 |
8-K
| Quarterly results |
| 10/27/2022 |
8-K
| Quarterly results |
| 08/17/2022 |
8-K
| Quarterly results |
| 07/20/2022 |
8-K
| Quarterly results |
| 07/15/2022 |
8-K
| Quarterly results |
| 05/23/2022 |
8-K
| Quarterly results |
| 05/17/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
8-K
| Quarterly results |
| 04/25/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.",
"CONVERTIBLE LOAN AGREEMENT THIS CONVERTIBLE LOAN AGREEMENT is made as of the 21st day of April, 2022 , by and among the lender listed on Exhibit A hereto and Orgenesis Inc. . WHEREAS, the Lenders desire to lend to the Borrower, and the Borrower desires to receive from the Lenders, an aggregate amount of US$5,000,000 pursuant to the terms set forth herein; NOW, THEREFORE, in consideration of the premises and the mutual covenants herein contained, and other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree as follows: 1. Loan; Closing . Terms of Loan . The Lenders shall lend to the Borrower, and the Borrower shall borrow from the Lenders, the Loan Amount listed next to their name on Exhibit A hereto. The Loan Amount shall be..." |
|
| 04/05/2022 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...|
Docs:
|
"WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.",
"FORM OF WARRANT APPENDIX I",
"REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement is made and entered into as of March 30, 2022, by and among Orgenesis Inc., a Nevada corporation , and the investors signatory hereto . RECITAL This Agreement is made pursuant to the Stock Purchase Agreement, dated as of March 30, 2022, among the Company and the Purchasers . AGREEMENT NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each of the Purchasers hereby agree as follows: SECTION 1. Definitions Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As u...",
"Orgenesis Inc. Announces $14.8 Million Private Placement" |
|
| 03/30/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 12/17/2021 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 10/15/2021 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/09/2021 |
8-K
| Quarterly results |
| 12/21/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/23/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/23/2020 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 11/16/2020 |
8-K
| Asset disposition |
| 11/12/2020 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 10/21/2020 |
8-K
| Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibit... |
| 10/01/2020 |
8-K
| Quarterly results |
| 05/06/2020 |
8-K
| Quarterly results |
| 04/24/2020 |
8-K
| Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits |
|
|
|